BRÈVE publiée le 14/11/2025 à 17:59, il y a 11 mois 20 jours Fuller, Smith & Turner PLC : Activités récentes de rachat d'actions Rachat D'actions Fuller, Smith & Turner PLC Actions Ordinaires Bourse De Londres Actions Du Trésor
COMMUNIQUÉ DE PRESSE publié le 14/11/2025 à 17:54, il y a 11 mois 20 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchasing 20,000 of its 'A' ordinary shares at an average price of 647.4456 GBp per share, as part of its buyback program London Stock Exchange Fuller, Smith & Turner PLC Numis Securities Limited Share Purchase Buyback Program
BRÈVE publiée le 13/11/2025 à 19:04, il y a 11 mois 21 jours Fuller, Smith & Turner PLC Completes Share Buyback London Stock Exchange Share Buyback Treasury Shares Numis Securities Fuller’s
BRÈVE publiée le 13/11/2025 à 19:04, il y a 11 mois 21 jours Fuller, Smith & Turner PLC finalise le rachat de ses actions Rachat D'actions Numis Securities Bourse De Londres Fuller's Actions Du Trésor
COMMUNIQUÉ DE PRESSE publié le 13/11/2025 à 18:59, il y a 11 mois 21 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 4,782 of its 'A' Ordinary Shares as part of the share buyback programme, with details of prices and voting rights Voting Rights London Stock Exchange Fuller, Smith & Turner PLC Share Buyback Programme Treasury Shares
BRÈVE publiée le 10/11/2025 à 19:02, il y a 11 mois 24 jours Fuller, Smith & Turner PLC Buys Back Shares Voting Rights London Stock Exchange Ordinary Shares Share Buyback Market Abuse Regulation
BRÈVE publiée le 10/11/2025 à 19:02, il y a 11 mois 24 jours Fuller, Smith & Turner PLC rachète ses propres actions Rachat D'actions Droit De Vote Actions Ordinaires Bourse De Londres Réglementation Des Abus De Marché
COMMUNIQUÉ DE PRESSE publié le 10/11/2025 à 18:57, il y a 11 mois 24 jours Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announced the purchase of 8,144 of its 'A' Ordinary Shares of 40p each on the London Stock Exchange as part of its buyback program Voting Rights London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 06/11/2025 à 18:56, il y a 11 mois 28 jours Fuller, Smith & Turner PLC: Share Buyback Details London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller, Smith & Turner
BRÈVE publiée le 06/11/2025 à 18:56, il y a 11 mois 28 jours Fuller, Smith & Turner PLC : Détails du rachat d’actions Rachat D'actions Actions Ordinaires Bourse De Londres Fuller, Smith & Turner Actions Du Trésor
Publié le 04/11/2026 à 18:00, il y a 7 heures 25 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 7 heures 25 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 7 heures 42 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 2 heures 16 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 2 heures 26 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 3 heures 11 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 3 heures 21 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 1 heure 23 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 5 heures 44 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 6 heures Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 6 heures 42 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 7 heures 20 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
